As the only known target gene of miR-26a, EZH2, acting as an oncogene, was shown to be involved in proliferation of different cell types, including tumor cell lines [54]; it showed oncogenic activity and tumor transformation requiring histone methylatransferase activity. This evidence concerns the gene EZH2 and neoplasm.